相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CDK4/6 inhibitors in breast cancer therapy: Current practice and future opportunities
Filipa Lynce et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Role of modern immunotherapy in gastrointestinal malignancies: a review of current clinical progress
Zin W. Myint et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Discordance in HER2 Status in Gastro-esophageal Adenocarcinomas: A Systematic Review and Meta-analysis
A. Creemers et al.
SCIENTIFIC REPORTS (2017)
Targeting PAK1
Galina Semenova et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2017)
Androgen Receptor and Androgen-Responsive Gene FKBP5 Are Independent Prognostic Indicators for Esophageal Adenocarcinoma
Eric Smith et al.
DIGESTIVE DISEASES AND SCIENCES (2016)
CD151 Gene and Protein Expression Provides Independent Prognostic Information for Patients with Adenocarcinoma of the Esophagus and Gastroesophageal Junction Treated by Esophagectomy
Oliver M. Fisher et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Targeting the MET Pathway in Gastric and Oesophageal Cancers: Refining the Optimal Approach
J. Lee et al.
CLINICAL ONCOLOGY (2016)
BER2 expression in oesophageal carcinoma and Barrett's oesophagus associated adenocarcinoma: An Australian study
V. Nagaraja et al.
EJSO (2016)
Evaluation of MMP-9 and MMP-2 and their suppressor TIMP-1 and TIMP-2 in adenocarcinoma of esophagogastric junction
Xiaofei Lu et al.
ONCOTARGETS AND THERAPY (2016)
Reduced genomic tumor heterogeneity after neoadjuvant chemotherapy is related to favorable outcome in patients with esophageal adenocarcinoma
Askar Obulkasim et al.
ONCOTARGET (2016)
Discordant HER2 expression and response to neoadjuvant chemoradiotherapy in esophagogastric adenocarcinoma
Ellie Chan et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2016)
EGFR family and cMet expression profiles and prognostic significance in esophagogastric adenocarcinoma
Ellie Chan et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2016)
Expression of IFITM1 as a prognostic biomarker in resected gastric and esophageal adenocarcinoma
David Borg et al.
BIOMARKER RESEARCH (2016)
Smad4 Loss in Esophageal Adenocarcinoma Is Associated With an Increased Propensity for Disease Recurrence and Poor Survival
Aatur D. Singhi et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
LC3B globular structures correlate with survival in esophageal adenocarcinoma
Shereen El-Mashed et al.
BMC CANCER (2015)
Systematic review and meta-analysis of immunohistochemical prognostic biomarkers in resected oesophageal adenocarcinoma
L. H. McCormick Matthews et al.
BRITISH JOURNAL OF CANCER (2015)
MIC-1/GDF15 in Barrett's oesophagus and oesophageal adenocarcinoma
O. M. Fisher et al.
BRITISH JOURNAL OF CANCER (2015)
Discovery and validation of vascular endothelial growth factor (VEGF) pathway polymorphisms in esophageal adenocarcinoma outcome
Lawson Eng et al.
CARCINOGENESIS (2015)
GATA6 expression in Barrett's oesophagus and oesophageal adenocarcinoma
Kirill Pavlov et al.
DIGESTIVE AND LIVER DISEASE (2015)
Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma
Joel H. Rubenstein et al.
GASTROENTEROLOGY (2015)
Biomarker: Predictive or Prognostic?
Karla V. Ballman
JOURNAL OF CLINICAL ONCOLOGY (2015)
The role of biological markers of epithelial to mesenchymal transition in oesophageal adenocarcinoma, an immunohistochemical study
M. J. D. Prins et al.
JOURNAL OF CLINICAL PATHOLOGY (2015)
Cancer-associated fibroblasts predict poor outcome and promote periostin-dependent invasion in oesophageal adenocarcinoma
Timothy J. Underwood et al.
JOURNAL OF PATHOLOGY (2015)
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
Joel Shapiro et al.
LANCET ONCOLOGY (2015)
CD44, SHH and SOX2 as novel biomarkers in esophageal cancer patients treated with neoadjuvant chemoradiotherapy
Judith Honing et al.
RADIOTHERAPY AND ONCOLOGY (2015)
Epidermal Growth Factor (EGFR) copy number aberrations in esophageal and gastro-esophageal junctional carcinoma
Asa Dahle-Smith et al.
MOLECULAR CYTOGENETICS (2015)
Epithelial PD-L2 Expression Marks Barrett's Esophagus and Esophageal Adenocarcinoma
Sarah Derks et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Carbohydrate antigen 19-9 is a useful prognostic marker in esophagogastric junction adenocarcinoma
Ryuma Tokunaga et al.
CANCER MEDICINE (2015)
High Expression of Cathepsin E in Tissues but Not Blood of Patients with Barrett's Esophagus and Adenocarcinoma
Oliver M. Fisher et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Whole-miRNome profiling identifies prognostic serum miRNAs in esophageal adenocarcinoma: the influence of Helicobacter pylori infection status
Rihong Zhai et al.
CARCINOGENESIS (2015)
Personalizing risk stratification by addition of PAK1 expression to TNM staging: Improving the accuracy of clinical decision for gastroesophageal junction adenocarcinoma
Zongtai Li et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Tumor-infiltrating neutrophils predict poor outcome in adenocarcinoma of the esophagogastric junction
Pingping Hu et al.
TUMOR BIOLOGY (2015)
Overview of multimodal therapy for adenocarcinoma of the esophagogastric junction
Kei Hosoda et al.
GENERAL THORACIC AND CARDIOVASCULAR SURGERY (2015)
Loss of CD44 and SOX2 Expression is Correlated with a Poor Prognosis in Esophageal Adenocarcinoma Patients
Judith Honing et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
IGFBP7 is associated with poor prognosis in oesophageal adenocarcinoma and is regulated by promoter DNA methylation
E. Smith et al.
BRITISH JOURNAL OF CANCER (2014)
Leptin and adiponectin receptor expression in oesophageal cancer
J. M. Howard et al.
BRITISH JOURNAL OF SURGERY (2014)
Snail1 correlates with patient outcomes in E-cadherin-preserved gastroesophageal junction adenocarcinoma
H. Dong et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2014)
Prognostic impact of TAZ and β-catenin expression in adenocarcinoma of the esophagogastric junction
Lidan Sun et al.
DIAGNOSTIC PATHOLOGY (2014)
Investigation of the epithelial to mesenchymal transition markers S100A4, vimentin and Snail1 in gastroesophageal junction tumors
A. Mirza et al.
DISEASES OF THE ESOPHAGUS (2014)
Overexpression of CMET is associated with signal transducer and activator of transcription 3 activation and diminished prognosis in oesophageal adenocarcinoma but not in squamous cell carcinoma
Ildiko Mesteri et al.
EUROPEAN JOURNAL OF CANCER (2014)
MUC2 expression is an adverse prognostic factor in superficial gastroesophageal adenocarcinomas
Jon M. Davison et al.
HUMAN PATHOLOGY (2014)
Evaluation of the HER2 amplification status in oesophageal adenocarcinoma by conventional and automated FISH: a tissue microarray study
M. J. D. Prins et al.
JOURNAL OF CLINICAL PATHOLOGY (2014)
Esophageal Carcinoma
Anil K. Rustgi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
The Degree of Segmental Aneuploidy Measured by Total Copy Number Abnormalities Predicts Survival and Recurrence in Superficial Gastroesophageal Adenocarcinoma
Jon M. Davison et al.
PLOS ONE (2014)
EGFR intron-1 CA repeat polymorphism is a predictor of relapse and survival in complete resected only surgically treated esophageal cancer
Yogesh K. Vashist et al.
TARGETED ONCOLOGY (2014)
FGFR2, HER2 and cMet in gastric adenocarcinoma: detection, prognostic significance and assessment of downstream pathway activation
Guy Betts et al.
VIRCHOWS ARCHIV (2014)
Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapy
Michaela Aichler et al.
ONCOTARGET (2014)
Heat Shock Protein 90 (HSP90) and Her2 in Adenocarcinomas of the Esophagus
Julia Slotta-Huspenina et al.
CANCERS (2014)
Breast cancer resistance protein (BCRP) and excision repair cross complement-1 (ERCC1) expression in esophageal cancers and response to cisplatin and irinotecan based chemotherapy
Anubha Bharthuar et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2014)
The significance of the HER-2 status in esophageal adenocarcinoma for survival: an immunohistochemical and an in situ hybridization study
M. J. D. Prins et al.
ANNALS OF ONCOLOGY (2013)
Clinicopathologic features and treatment outcomes of patients with human epidermal growth factor receptor 2-positive adenocarcinoma of the esophagus and gastroesophageal junction
B. E. Phillips et al.
DISEASES OF THE ESOPHAGUS (2013)
Epidermal growth factor receptor, phosphatidylinositol-3-kinase catalytic subunit/PTEN, and KRAS/NRAS/BRAF in primary resected esophageal adenocarcinomas: loss of PTEN is associated with worse clinical outcome
Marcus Bettstetter et al.
HUMAN PATHOLOGY (2013)
Lymphangiogenesis and Prognostic Significance of Vascular Endothelial Growth Factor C in Gastro-oesophageal Junction Adenocarcinoma
Liang-Xi Xie et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2013)
Three-Gene Immunohistochemical Panel Adds to Clinical Staging Algorithms to Predict Prognosis for Patients With Esophageal Adenocarcinoma
Chin-Ann J. Ong et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Over-expression of phosphorylated mammalian target of rapamycin is associated with poor survival in oesophageal adenocarcinoma: a tissue microarray study
Margriet J. D. Prins et al.
JOURNAL OF CLINICAL PATHOLOGY (2013)
Association of MDM2 T309G and p53 Arg72Pro polymorphisms and gastroesophageal reflux disease with survival in esophageal adenocarcinoma
Daniel J. Renouf et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Gene expression profiles in esophageal adenocarcinoma predict survival after resection
Arjun Pennathur et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2013)
Genetic Polymorphisms at TIMP3 Are Associated with Survival of Adenocarcinoma of the Gastroesophageal Junction
Morteza Bashash et al.
PLOS ONE (2013)
The Metastasis-Associated Gene MTA3, a Component of the Mi-2/NuRD Transcriptional Repression Complex, Predicts Prognosis of Gastroesophageal Junction Adenocarcinoma
Hongmei Dong et al.
PLOS ONE (2013)
Disseminated Tumor Cells in Bone Marrow and the Natural Course of Resected Esophageal Cancer
Yogesh K. Vashist et al.
ANNALS OF SURGERY (2012)
Role of the insulin-like growth factor 1 axis and visceral adiposity in oesophageal adenocarcinoma
C. L. Donohoe et al.
BRITISH JOURNAL OF SURGERY (2012)
Association of HER2/ErbB2 Expression and Gene Amplification with Pathologic Features and Prognosis in Esophageal Adenocarcinomas
Harry H. Yoon et al.
CLINICAL CANCER RESEARCH (2012)
Mucin 16 (cancer antigen 125) expression in human tissues and cell lines and correlation with clinical outcome in adenocarcinomas of the pancreas, esophagus, stomach, and colon
Mirte M. Streppel et al.
HUMAN PATHOLOGY (2012)
Adverse Prognostic Impact of Intratumor Heterogeneous HER2 Gene Amplification in Patients With Esophageal Adenocarcinoma
Harry H. Yoon et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Cyclooxygenase Isoenzyme-2 and Vascular Endothelial Growth Factor are Associated with Poor Prognosis in Esophageal Adenocarcinoma
M. J. D. Prins et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2012)
Evidence of Prognostic Relevant Expression Profiles of Heat-Shock Proteins and Glucose-Regulated Proteins in Oesophageal Adenocarcinomas
Julia Slotta-Huspenina et al.
PLOS ONE (2012)
SULF2 expression by immunohistochemistry and overall survival in oesophageal cancer: a cohort study
Natalie Shaubie Lui et al.
BMJ OPEN (2012)
Genetic Variants in DNA Repair Predicts the Survival of Patients with Esophageal Cancer
Jang-Ming Lee et al.
ANNALS OF SURGERY (2011)
Clinical Significance of the Costimulatory Molecule B7-H1 in Barrett Carcinoma
Martin Loos et al.
ANNALS OF THORACIC SURGERY (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Integrative analysis of array-comparative genomic hybridisation and matched gene expression profiling data reveals novel genes with prognostic significance in oesophageal adenocarcinoma
X. Y. Goh et al.
GUT (2011)
Prognostic significance of differentially expressed miRNAs in esophageal cancer
Yuxin Hu et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
LgR5 expression and cancer stem cell hypothesis: clue to define the true origin of esophageal adenocarcinomas with and without Barrett's Esophagus?
Burkhard H. A. von Rahden et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2011)
Assessment of ErbB2 (Her2) in oesophageal adenocarcinomas: summary of a revised immunohistochemical evaluation system, bright field double in situ hybridisation and fluorescence in situ hybridisation
Rupert Langer et al.
MODERN PATHOLOGY (2011)
Glucocorticoid-induced TNFR family-related receptor (GITR)-expression in tumor infiltrating leucocytes (TILs) is associated with the pathogenesis of esophageal adenocarcinomas with and without Barrett's mucosa
Burkhard H. A. von Randen et al.
CANCER BIOMARKERS (2010)
Inflammatory and MicroRNA Gene Expression as Prognostic Classifier of Barrett's-Associated Esophageal Adenocarcinoma
Giang Huong Nguyen et al.
CLINICAL CANCER RESEARCH (2010)
Lgr5, an intestinal stem cell marker, is abnormally expressed in Barrett's esophagus and esophageal adenocarcinoma
L. Becker et al.
DISEASES OF THE ESOPHAGUS (2010)
Prognostic value of p53 mutations in oesophageal adenocarcinoma: final results of a 15-year prospective study
Koroush Madani et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2010)
MMP-1 is a (pre-)invasive factor in Barrett-associated esophageal adenocarcinomas and is associated with positive lymph node status
Martin Grimm et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2010)
Prognostic Biomarkers for Esophageal Adenocarcinoma Identified by Analysis of Tumor Transcriptome
Soo Mi Kim et al.
PLOS ONE (2010)
Frequent Loss of Heterozygosity of Chromosome 1q in Esophageal Adenocarcinoma Loss of Chromosome 1q21.3 Is Associated With Shorter Overall Survival
Dipen M. Maru et al.
CANCER (2009)
Matrix metalloproteinase 1, 3 and 12 polymorphisms and esophageal adenocarcinoma risk and prognosis
Penelope A. Bradbury et al.
CARCINOGENESIS (2009)
p53 Arg72Pro and MDM2 T309G Polymorphisms, Histology, and Esophageal Cancer Prognosis
David W. Cescon et al.
CLINICAL CANCER RESEARCH (2009)
Vascular Endothelial Growth Factor Polymorphisms and Esophageal Cancer Prognosis
Penelope A. Bradbury et al.
CLINICAL CANCER RESEARCH (2009)
Progressive silencing of p14ARF in oesophageal adenocarcinoma
Yinghui Huang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Genetic Variations in the PI3K/PTEN/AKT/mTOR Pathway Are Associated With Clinical Outcomes in Esophageal Cancer Patients Treated With Chemoradiotherapy
Michelle A. T. Hildebrandt et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Cisplatin pharmacogenetics, DNA repair polymorphisms, and esophageal cancer outcomes
Penelope A. Bradbury et al.
PHARMACOGENETICS AND GENOMICS (2009)
Expression and clinical significance of Glucose Regulated Proteins GRP78 (BiP) and GRP94 (GP96) in human adenocarcinomas of the esophagus
Rupert Langer et al.
BMC CANCER (2008)
Prognostic value of cell adhesion in esophageal adenocarcinomas
D. Falkenback et al.
DISEASES OF THE ESOPHAGUS (2008)
Assessment of a HER2 scoring system for gastric cancer:: results from a validation study
M. Hofmann et al.
HISTOPATHOLOGY (2008)
Significance of HER2 low-level copy gain in Barrett's cancer:: Implications for fluorescence in situ hybridization testing in tissues
Sandra Rauser et al.
CLINICAL CANCER RESEARCH (2007)
Clinical biology of esophageal adenocarcinoma after surgery is influenced by nuclear factor-κB expression
Julie G. Izzo et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Cyclin D1 guanine/adenine 870 polymorphism with altered protein expression is associated with genomic instability and aggressive clinical biology of esophageal adenocarcinoma
Julie G. Izzo et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas - Association with poor outcome
Kim L. Wang et al.
CANCER (2007)
Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: Association with poor outcome
Kim L. Wang et al.
CLINICAL CANCER RESEARCH (2006)
Prognostic significance of expression patterns of c-erbB-2, p53, p16INK4A, p27KIP1, cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma:: a tissue microarray study
R. Langer et al.
JOURNAL OF CLINICAL PATHOLOGY (2006)
Prognostic significance of cyclooxygenase-2 (COX-2) expression in patients with surgically resectable adenocarcinoma of the oesophagus
Pradeep Bhandari et al.
BMC CANCER (2006)
COX-2: A target for prevention and treatment of esophageal cancer
N Altorki
JOURNAL OF SURGICAL RESEARCH (2004)
分享论文
